The current sp just a reflection of SPT's future potential. I suggest that if you only care about the current revenue, please just buy the stock like A2M.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025